Author

Sharathchandra Arandkar

Homi Bhabha National InstituteORCID 0000-0001-6160-6338Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ghanapriya YengkhomiD· 2 shared Anjali Mange· 1 shared Arvind IngleiD· 1 shared Ashish Shingade· 1 shared Ashok Dudhalkar· 1 shared Jan A. SchlegeliD· 1 shared Jasmine Kaur· 1 shared Kumar PrabhashiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ghanapriya YengkhomORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 26, 2026

Occurrence of Biased mTOR Signaling in Hepatocellular Carcinoma

Rudransh Singh, Niriksha Patel, Neha Singh…·Sunil Shetty

This study identifies biased mTOR signaling in hepatocellular carcinoma (HCC) and shows that dual inhibition of mTORC1 and mTORC2 significantly reduces HCC progression.

DOI 10.64898/2026.05.22.727188

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 7, 2025

IGFBPs define distinct pro-tumorigenic CAF subtypes in lung cancer tumour-microenvironment

Ghanapriya Yengkhom, Kunal Khemraj Nandgaonkar, Saikishore Ramanathan…·Sharathchandra Arandkar

The paper identifies IGFBP5, 6, and 7 as key regulators of CAF heterogeneity in lung cancer, showing their role in promoting tumour growth and cisplatin resistance.

DOI 10.64898/2025.12.03.692056

humanbulk RNA-seq

𝕏 PostBluesky